scholarly journals Contraceptive Patch

2020 ◽  
Author(s):  
Keyword(s):  
Contraceptive Patch

New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study

Contraception ◽  
2015 ◽  
Vol 91 (3) ◽  
pp. 211-216 ◽  
Author(s):  
Andrew M. Kaunitz ◽  
David Portman ◽  
Carolyn L. Westhoff ◽  
Daniel R. Mishell ◽  
David F. Archer ◽  
...  
Keyword(s):  
Phase 3 ◽  
Contraceptive Patch

Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women

2015 ◽  
Vol 212 (3) ◽  
pp. 318.e1-318.e8 ◽  
Author(s):  
Andrew M. Kaunitz ◽  
David F. Archer ◽  
Daniel R. Mishell ◽  
Marie Foegh
Keyword(s):  
Low Dose ◽  
Contraceptive Patch

Adolescents' Use of the Transdermal Contraceptive Patch

2006 ◽  
Vol 19 (2) ◽  
pp. 145
Author(s):  
G.S. Sucato ◽  
S.R. Land ◽  
P.J. Murray ◽  
N. Boback ◽  
M.A. Gold
Keyword(s):  
Contraceptive Patch

scholarly journals Levonorgestrel contraceptive patch conferred no side effect profile differences in women of different racial backgrounds

2017 ◽  
Vol 108 (3) ◽  
pp. e124
Author(s):  
A.D. Greene ◽  
K. Barnhart ◽  
B. Chen ◽  
J. Jensen ◽  
S.B. Teal ◽  
...  
Keyword(s):  
Side Effect ◽  
Side Effect Profile ◽  
Contraceptive Patch

Contraceptive Patch

2017 ◽  
pp. 265-265
Author(s):  
Ashwini Bhalerao-Gandhi ◽  
Sanket Pisat
Keyword(s):  
Contraceptive Patch

scholarly journals Long-Term Evaluation of the Use of the Transdermal Contraceptive Patch in Adolescents

2004 ◽  
Vol 4 ◽  
pp. 512-516 ◽  
Author(s):  
Stephanie Logsdon ◽  
Jessica Richards ◽  
Hatim A. Omar
Keyword(s):  
Young Women ◽  
Skin Irritation ◽  
Adolescent Medicine ◽  
Outpatient Center ◽  
Term Evaluation ◽  
Complete Detachment ◽  
Lost To Follow Up ◽  
Contraceptive Patch

The transdermal contraceptive patch, Ortho Evra™, was approved in December 2001 and released on the market in June 2002. In this study, we reviewed clinical data of young women who started the patch between June 2002 and December 2003 in the adolescent medicine clinic at a university-based outpatient center. A total of 62 patients started the patch in that period and two of them were lost to follow-up. Mean age of patients was 17.9 years and mean length of use was 10 cycles. Only 10 patients (16.7%) discontinued use. Reasons for discontinuation were moderate to severe skin irritation (3 patients, 5%), complete detachment (3 patients, 5%), and economic reasons (4 patients, 6.7%). Compliance was excellent overall and the side-effects profile was good. No pregnancies occurred during this period. These results confirmed that the transdermal contraceptive patch is easy to use and an effective method of birth control that may be better tolerated by young women. It also seemed to improve contraceptive compliance in this population.

Adolescents’ Experiences Using the Contraceptive Patch versus Pills

2011 ◽  
Vol 24 (4) ◽  
pp. 197-203 ◽  
Author(s):  
Gina S. Sucato ◽  
Stephanie R. Land ◽  
Pamela J. Murray ◽  
Reena Cecchini ◽  
Melanie A. Gold
Keyword(s):  
Contraceptive Patch
Sign in / Sign up

Export Citation Format

Share Document